LV EDWT | LV EDWT | p-value | |||||
---|---|---|---|---|---|---|---|
Total | ≤12 mm | >12 mm | |||||
n = 175 | n = 98 | n = 77 | |||||
Patient Characteristics | |||||||
Age (yrs) | 69 | (± 12) | 65 | (± 15) | 71 | (± 10) | 0.013 |
Gender Women, Men | 102 | 73.0 | 63 | 35.0 | 39 | 38.0 | 0.07 |
Weight (kg) | 92.2 | (± 23.4) | 90.6 | (± 23.0) | 94.3 | (± 23.7) | 0.32 |
BSA (m2) | 2.3 | (± 0.7) | 2.1 | (± 0.7) | 2.4 | (± 0.8) | 0.56 |
Wall Thickness | 12.3 | (± 3.1) | 9.2 | (± 0.8) | 16.0 | (± 2.4) | 0.0001 |
Historical Information | |||||||
Prior CAD | 81 | (50.0%) | 41 | (41.8%) | 40 | (51.9%) | 0.190 |
Prior Revascularization | 28 | (16.0%) | 10 | (10.2%) | 18 | (23.4%) | 0.018 |
Hypertension | 112 | (64.0%) | 52 | (53.1%) | 60 | (77.9%) | 0.0006 |
Diabetes Melitus | 51 | (29.1%) | 23 | (23.5%) | 28 | (36.4%) | 0.063 |
Hyperlipidemia | 89 | (50.9%) | 46 | (46.9%) | 43 | (55.8%) | 0.240 |
Smoking | 64 | (36.6%) | 31 | (31.6%) | 33 | (42.9%) | 0.130 |
Asthma/COPD | 39 | (22.3%) | 16 | (16.3%) | 23 | (29.9%) | 0.033 |
Medications | |||||||
Digoxin | 9 | (5.1%) | 6 | (6.1%) | 3 | (3.9%) | 0.51 |
Vasodilator | 14 | (8.0%) | 7 | (7.1%) | 28 | (36.4%) | 0.64 |
Diuretic | 60 | (34.3%) | 32 | (32.7%) | 28 | (36.4%) | 0.61 |
Beta Blocker | 54 | (30.9%) | 23 | (23.5%) | 31 | (40.3%) | 0.017 |
Calcium Antagonist | 32 | (18.3%) | 13 | (13.3%) | 19 | (24.7%) | 0.053 |
ASA | 82 | (46.9%) | 43 | (43.9%) | 39 | (50.6%) | 0.38 |
Nitrate | 45 | (25.7%) | 20 | (20.4%) | 25 | (32.5%) | 0.071 |
ACE Inhibitor | 39 | (22.3%) | 16 | (16.3%) | 23 | (29.9%) | 0.033 |
Anti-Coagulation | 15 | (8.6%) | 4 | (4.1%) | 11 | (14.3%) | 0.017 |
Statin | 65 | (37.1%) | 28 | (28.6%) | 37 | (48.1%) | 0.0079 |